Skip to content
CC PHARM [RSI] | Vecuronium episode artwork

Aug 25, 2026 34 min

CC PHARM [RSI] | Vecuronium

from STAT Stitch Deep Dive Podcast Beyond The Bedside

Vecuronium is an intermediate-acting, nondepolarizing neuromuscular blocking agent used for skeletal muscle relaxation during surgery, mechanical ventilation, and endotracheal intubation, including rapid-sequence intubation (RSI). 1. Critical Safety & Boxed Warning (The Vital 20%) Respiratory Paralysis: Causes respiratory paralysis (potentially fatal). Administer only by experienced clinicians in settings with immediate intubation, ventilation, oxygen, and reversal agents. Induction Prerequisite: To prevent extreme distress, vecuronium must only be administered after unconsciousness is induced with adequate amnesia, sedation, and analgesia. Storage Warning: Due to risk of fatal accidental administration, store vials with cap/ferrule intact and separated from other drugs to prevent selection errors. 2. Mechanism of Action & Pharmacokinetics Mechanism: Competes with acetylcholine (ACh) for receptors at the motor end-plate. Paralysis progresses predictably: fine muscles (eyes, face, neck) first, then limbs, chest, abdomen, and lastly the diaphragm. Recovery occurs in reverse order. Onset & Duration: IV administration acts within 1 minute, peaks at 3 to 5 minutes, and lasts 25 to 40 minutes. Metabolism & Elimination: 60% to 80% protein-bound. Active 3-desacetyl metabolite has 50% to 70% potency of parent compound. Elimination half-life: 65 mins (infants), 41 mins (children), and 65 to 75 mins (adults). 3. Core Clinical Dosing Rapid-Sequence Intubation (RSI): Adults: 0.1-0.2 mg/kg IV (onset 2-4 mins). Pediatrics (7 weeks to 17 years): 0.15-0.2 mg/kg IV (onset 2.5-3 mins). Neonates (<7 weeks): 0.1 mg/kg IV (onset 2.5-3 mins). Mechanical Ventilation & Surgery: Adults: 0.08-0.1 mg/kg initial IV bolus, then 0.01-0.015 mg/kg every 12-15 mins as needed, or continuous infusion of 0.8-1.7 mcg/kg/min. Defasciculation: 0.01 mg/kg IV given 1-3 mins before succinylcholine in adults. Rare in pediatrics. 4. Reconstitution & Stability Reconstitution: Add 10 or 20 mL of Bacteriostatic Water to 10 or 20 mg vials (1 mg/mL). For neonates, use Sterile Water to avoid benzyl alcohol toxicity. Storage: Bacteriostatic water reconstitution lasts 5 days (room temp/refrigerated); Sterile Water is single-use and discarded within 24 hours. Do not mix with alkaline solutions. 5. Monitoring & Adverse Effects Monitoring: Use a peripheral nerve stimulator to monitor response (target: 1 to 2 twitches). Adverse Reactions: Major risks include bronchospasm, anaphylaxis, acute myopathy, prolonged paralysis, tachycardia, and hypotension. Minimal histamine release occurs. 📊 I can generate a quick reference dosing card or a cheat sheet comparing these pediatric vs. adult infusion rates for your clinical review.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

CC PHARM [RSI] | Vecuronium

0:00 34:58

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of STAT Stitch Deep Dive Podcast Beyond The Bedside?

This episode is 34 minutes long.

When was this STAT Stitch Deep Dive Podcast Beyond The Bedside episode published?

This episode was published on August 25, 2026.

Can I download this STAT Stitch Deep Dive Podcast Beyond The Bedside episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.